Close
Back to ULTI Stock Lookup

Ultimovacs (ULTI) – FDA

Jun 1, 2021 08:02 AM Ultimovacs (ULTI) Announces Publication in The Journal of Translational Medicine on Mechanistic Rationale of UV1 Cancer Vaccine Supporting Phase 2 Study Design in Malignant Mesothelioma

Back to ULTI Stock Lookup